Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Monitoring tumor response to linifanib therapy with SPECT/CT using the integrin αvβ3-targeted radiotracer 99mTc-3P-RGD2.

Ji S, Zhou Y, Voorbach MJ, Shao G, Zhang Y, Fox GB, Albert DH, Luo Y, Liu S, Mudd SR.

J Pharmacol Exp Ther. 2013 Aug;346(2):251-8. doi: 10.1124/jpet.112.202622. Epub 2013 Jun 7.

2.
3.

(99m)Tc-3P-RGD2 micro-single-photon emission computed tomography/computed tomography provides a rational basis for integrin αvβ3-targeted therapy.

Fu T, Qu W, Qiu F, Li Y, Shao G, Tian W, Hua Z, Zhang Y, Wang F.

Cancer Biother Radiopharm. 2014 Nov;29(9):351-8. doi: 10.1089/cbr.2014.1622. Epub 2014 Oct 6.

4.

Impact of multiple negative charges on blood clearance and biodistribution characteristics of 99mTc-labeled dimeric cyclic RGD peptides.

Yang Y, Ji S, Liu S.

Bioconjug Chem. 2014 Sep 17;25(9):1720-9. doi: 10.1021/bc500309r. Epub 2014 Aug 21.

5.

Monitoring glioma growth and tumor necrosis with the U-SPECT-II/CT scanner by targeting integrin αvβ3.

Shao G, Zhou Y, Wang F, Liu S.

Mol Imaging. 2013 Jan-Feb;12(1):39-48.

PMID:
23348790
6.

(99m)Tc-Galacto-RGD2: a novel 99mTc-labeled cyclic RGD peptide dimer useful for tumor imaging.

Ji S, Czerwinski A, Zhou Y, Shao G, Valenzuela F, Sowiński P, Chauhan S, Pennington M, Liu S.

Mol Pharm. 2013 Sep 3;10(9):3304-14. doi: 10.1021/mp400085d. Epub 2013 Aug 6.

7.

99mTc-labeled cyclic RGD peptides for noninvasive monitoring of tumor integrin αVβ3 expression.

Zhou Y, Kim YS, Chakraborty S, Shi J, Gao H, Liu S.

Mol Imaging. 2011 Oct;10(5):386-97. doi: 10.2310/7290.2011.00006. Epub 2011 Apr 26.

PMID:
21521559
8.

Tumor uptake of the RGD dimeric probe (99m)Tc-G3-2P4-RGD2 is correlated with integrin αvβ3 expressed on both tumor cells and neovasculature.

Liu Z, Jia B, Shi J, Jin X, Zhao H, Li F, Liu S, Wang F.

Bioconjug Chem. 2010 Mar 17;21(3):548-55. doi: 10.1021/bc900547d. Epub 2010 Feb 25.

PMID:
20184307
9.

FITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissues.

Zheng Y, Ji S, Czerwinski A, Valenzuela F, Pennington M, Liu S.

Bioconjug Chem. 2014 Nov 19;25(11):1925-41. doi: 10.1021/bc500452y. Epub 2014 Oct 22.

10.

(99m)Tc-3P-RGD2 SPECT to monitor early response to bevacizumab therapy in patients with advanced non-small cell lung cancer.

Chen B, Zhao G, Ma Q, Ji B, Ji T, Xin H, Gao S.

Int J Clin Exp Pathol. 2015 Dec 1;8(12):16064-72. eCollection 2015 Dec 1.

11.

Comparison of biological properties of (111)In-labeled dimeric cyclic RGD peptides.

Zheng Y, Ji S, Tomaselli E, Yang Y, Liu S.

Nucl Med Biol. 2015 Feb;42(2):137-45. doi: 10.1016/j.nucmedbio.2014.10.005. Epub 2014 Oct 14.

PMID:
25459111
12.

Diversity of RGD radiotracers in monitoring antiangiogenesis of flavopiridol and paclitaxel in ovarian cancer xenograft-bearing mice.

Yang G, Sun H, Kong Y, Hou G, Han J.

Nucl Med Biol. 2014 Nov-Dec;41(10):856-62. doi: 10.1016/j.nucmedbio.2014.08.008. Epub 2014 Aug 13.

PMID:
25195014
13.

Specific uptake of 99mTc-NC100692, an αvβ3-targeted imaging probe, in subcutaneous and orthotopic tumors.

Dearling JL, Barnes JW, Panigrahy D, Zimmerman RE, Fahey F, Treves ST, Morrison MS, Kieran MW, Packard AB.

Nucl Med Biol. 2013 Aug;40(6):788-94. doi: 10.1016/j.nucmedbio.2013.04.006. Epub 2013 May 20.

14.

Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer.

Liu S, Hsieh WY, Jiang Y, Kim YS, Sreerama SG, Chen X, Jia B, Wang F.

Bioconjug Chem. 2007 Mar-Apr;18(2):438-46. Epub 2007 Mar 7.

PMID:
17341108
15.

Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers.

Wang L, Shi J, Kim YS, Zhai S, Jia B, Zhao H, Liu Z, Wang F, Chen X, Liu S.

Mol Pharm. 2009 Jan-Feb;6(1):231-45. doi: 10.1021/mp800150r.

16.

Iminodiacetic acid as bifunctional linker for dimerization of cyclic RGD peptides.

Xu D, Zhao ZQ, Chen ST, Yang Y, Fang W, Liu S.

Nucl Med Biol. 2017 Jan 20;48:1-8. doi: 10.1016/j.nucmedbio.2017.01.007. [Epub ahead of print]

PMID:
28157625
17.

Comparison of biological properties of 99mTc-labeled cyclic RGD Peptide trimer and dimer useful as SPECT radiotracers for tumor imaging.

Zhao ZQ, Yang Y, Fang W, Liu S.

Nucl Med Biol. 2016 Nov;43(11):661-669. doi: 10.1016/j.nucmedbio.2016.02.006. Epub 2016 Feb 27.

PMID:
27556955
18.

[99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.

Decristoforo C, Faintuch-Linkowski B, Rey A, von Guggenberg E, Rupprich M, Hernandez-Gonzales I, Rodrigo T, Haubner R.

Nucl Med Biol. 2006 Nov;33(8):945-52.

PMID:
17127166
19.

Imaging integrin αvβ3 on blood vessels with 111In-RGD2 in head and neck tumor xenografts.

Terry SY, Abiraj K, Frielink C, van Dijk LK, Bussink J, Oyen WJ, Boerman OC.

J Nucl Med. 2014 Feb;55(2):281-6. doi: 10.2967/jnumed.113.129668. Epub 2014 Jan 9.

20.

99mTc-labeled cyclic RGDfK dimer: initial evaluation for SPECT imaging of glioma integrin alphavbeta3 expression.

Jia B, Shi J, Yang Z, Xu B, Liu Z, Zhao H, Liu S, Wang F.

Bioconjug Chem. 2006 Jul-Aug;17(4):1069-76.

PMID:
16848417

Supplemental Content

Support Center